NYSE ARCA | ETF
The adviser seeks to meet its objective by investing primarily in equities, including common stock, preferred stock and bonds which are convertible to common stock, that the adviser identifies to be attractively valued given their growth potential over a long-term time horizon.
The securities held by the fund will predominantly be of companies with market capitalizations similar to those within the universe of the Russell 1000 Value Index (which includes both large cap and mid cap companies).
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
MJGXX | JPMorgan Trust II - JPMorgan U.S. Government Money Market Fund | 4.43% | ||
WFC | Wells Fargo & Company | Financial Services | Banks - Diversified | 3.08% |
BAC | Bank of America Corp | Financial Services | Banks - Diversified | 2.80% |
PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 2.38% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.33% |
BRK-B | Berkshire Hathaway Inc | Financial Services | Insurance - Diversified | 2.31% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.04% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.69% |
CI | Cigna Corp | Healthcare | Healthcare Plans | 1.61% |
CARR | Carrier Global Corp | Industrials | Building Products & Equipment | 1.61% |
RTX | Raytheon Technologies Corp | Industrials | Aerospace & Defense | 1.60% |
XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 1.48% |
COP | ConocoPhillips | Energy | Oil & Gas E&P | 1.35% |
VZ | Verizon Communications Inc | Communication Services | Telecom Services | 1.27% |
FCNCA | First Citizens BancShares Inc | Financial Services | Banks - Regional | 1.27% |
FISV | Fiserv Inc. | Technology | Information Technology Services | 1.24% |
CVX | Chevron Corp | Energy | Oil & Gas Integrated | 1.15% |
CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 1.14% |
WMT | Walmart Inc | Consumer Defensive | Discount Stores | 1.06% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.05% |